Federal Register / Vol. 71, No. 222 / Friday, November 17, 2006 / Notices 66957 

Rockville, MD 20850, 240–276–0491, 

ext. 161, or FDA Advisory Committee 

Information Line, 1–800–741–8138 

(301–443–0572 in the Washington, DC 

area), code 3014512514. Please call the 

Information Line for up-to-date 

information on this meeting. 

Agenda: The committee will hear an 

update on the status of recent devices 

brought before the committee. The 

committee will also hear a presentation 

regarding the FDA Critical Path 

Initiative. The committee will discuss 

general issues concerning high and low 

density lipoprotein subfraction assays. 

Background information, including the 

agenda and questions for the committee, 

will be available to the public 1 

business day before the meeting on the 

Internet at http://www.fda.gov/cdrh/ 

panel/index.html. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before November 24, 2006. 

Oral presentations from the public will 

be scheduled for approximately 30 

minutes at the beginning of committee 

deliberations and for approximately 30 

minutes near the end of the 

deliberations. Time allotted for each 

presentation may be limited. Those 

desiring to make formal oral 

presentations should notify the contact 

person and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation on or before 

November 24, 2006. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Shirley 

Meeks, Conference Management Staff, 

301–827–7292 at least 7 days in advance 

of the meeting. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: November 8, 2006. 

Randall W. Lutter, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E6–19492 Filed 11–16–06; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institutes of Child Health and 

Human Development; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Board of Medical 

Rehabilitation Research. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Advisory 

Board on Medical Rehabilitation Research. 

Date: December 7–8, 2006. 

Time: December 7, 2006, 8:30 a.m. to 5 

p.m. 

Agenda: NICHD Director’s Report 

presentation, NCMRR Director’s Report 

presentation and various reports on Medical 

Research Initiatives. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Time: December 8, 2006, 8:30 a.m. to 12:00 

p.m. 

Agenda: Other business dealing with the 

NABMRR Board. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda,MD 20814. 

Contact Person: Ralph M. Nitkin, PhD, 

Director, BSCD, National Center for Medical, 

Rehabilitation Research, National Institute of 

Child Health, and Human Development, NIH, 

6100 Building, Room 2A03, Bethesda, MD 

20892. (301) 402–4206. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nichd.nih.gov/about/ncmrr.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: November 13, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9254 Filed 11–16–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Children’s Study Advisory 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Children’s 

Study Advisory Committee. 

Date: December 5, 2006. 

Time: 9 a.m. to 5 p.m. 

Agenda: For questions or to register, please 

call Circle Solutions at (703) 902–1139 or via 

the Web site http://www.circlesolutions.com/ 

ncs/ncsac. Advanced registration is required 

due to space limitations. Registration 

deadline is November 28, 2006. The agenda 

will include progress regarding the study 

plan and protocol, informed consent and 

genetic aspects of the study. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852. 

Contact Person: Marion Balsam, MD, 

Executive Secretary, National Children’s 

Study Advisory Committee, 6100 Executive 

Boulevard, Rockville, MD 20892. 301–594–

9147. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: November 13, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9255 Filed 11–16–06; 8:45 am] 

BILLING CODE 4140–01–M 


jlentini on PROD1PC65 with NOTICES